Efficacy of Popliteal Nerve Blocks With and Without Dexamethasone on the Duration of Analgesia for Foot & Ankle Surgery
NCT ID: NCT01975285
Last Updated: 2016-05-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2013-08-31
2014-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Ankle Surgery
NCT03332316
Analgesic Benefits of Perineural Versus Intravenous Dexamethasone in Patients Receiving Sciatic Nerve Block
NCT01616173
Perineural Steroids for Peripheral Nerve Blocks
NCT02462148
Protracted Effect of the Ultrasound-guided Saphenous Block
NCT02346110
Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery
NCT06086418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexamethasone group
Dexamethasone 4mg(1 ml) per 20cc
Dexamethasone
0.5% Bupivacaine with 1:200,000 epinephrine + Dexamethasone 4mg per 20cc
Saline group
Saline 1 ml per 20cc
Saline
0.5% Bupivacaine with 1:200,000epinephrine + Saline 1 ml per 20cc
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone
0.5% Bupivacaine with 1:200,000 epinephrine + Dexamethasone 4mg per 20cc
Saline
0.5% Bupivacaine with 1:200,000epinephrine + Saline 1 ml per 20cc
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness and ability to sign an informed consent document
* No allergies to anesthetic or analgesic medications
* American Society of Anesthesiologists (ASA)physical status Class I - III
* Aged 18-90 years,either sex
Exclusion Criteria
* Age\<18 or\> 90 years -
* Contraindications to regional blockage including but not limited to:
* Patient refusal to regional blockade
* Infection at the site of needle insertion
* Systemic infection
* Bleeding diathesis or coagulopathy
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roya Yumul, M.D.,PhD.
Residency program director, Department of anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roya Yumul, MD
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars Sinai Medical center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00032547
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.